Mechanism

Gut microbiome-immune axis

Assets acting on this target.

Class
Live biotherapeutic product (Akkermansia muciniphila) used as an immune-checkpoint-inhibitor sensitizer
Pathway
Colonization stimulates dendritic cell activation and CD4+/CD8+ T-cell trafficking/activation, restoring or enhancing response to anti-PD-(L)1 immunotherapy
Notes
original target text: Gut microbiome-immune axis (no single molecular receptor; a live bacterial biotherapeutic)
Research

Explore this mechanism at different depths

Research adds deeper and simplified explanation variants while preserving the same scientific register and source caveats.

Company

0 of 0 assets

No assets match these filters.

← all assets